万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/scie期刊 >>医药卫生>>传染免疫学

Endocrine(研究方向:内分泌学与代谢) (官网千亿国际平台)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置
  • 主要研究方向:

    等待设置主要研究方向
    待设置

    Endocrine(月刊),创刊于1994年,出版国家为美国,作为当今快速发展的实验和临床研究领域的主要期刊,Endocrine发表了专门用于所有不同领域的内分泌和代谢的基本(包括分子,细胞和生理学研究),翻译和临床研究的原创性文章。基于同行评审,优先级和编辑决定接受文章。Endocrine包括有争议的临床内分泌问题。也接受内分泌和代谢主题的元分析。可以考虑对单个患者的新的成像研究和内分泌副作用的报道。可以提交与最近发表的文章相关或不相...[显示全部]
    征稿信息

    万维提示:

    1、千亿国际平台方式:在线千亿国际平台。

    2、期刊官网:

    http://www.springer.com/medicine/internal/journal/12020

    3、期刊千亿国际平台:

    https://www.editorialmanager.com/endo/default.aspx

    4、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友千亿国际平台提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

    2017216日星期四

                              

     

    Instructions for authors

     

    Aims and Scope


    Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published.  Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.

     

    Endocrine covers controversial, clinical endocrine issues.  Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.

     

    Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.

     

    Endocrine’s editorial team is committed to provide rapid turn-around (first decision average just over three weeks) and publication within six months of acceptance.

     

    Manuscript categories

    1. Original article

    This contribution should contain original controlled experimental data of basic and clinical research. The manuscript should be organized in the following sections: Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, Figure Legends, Tables, Figures. Manuscripts should not exceed 4,000 words, 60 references, and 7 tables/figures

    2. Review

    This contribution is usually solicited by the Editors. If unsolicited, the authors are advised to contact the Editor-in-Chief (endocrine_eic@libero.it) with an outline of the proposed review and CV of the authors.

    This type of article does not have a strict limit in word and reference number although the editorial recommendation is that the article does not exceed 4000 words and 350 references.

    3. Mini-Review

    This contribution is also usually solicited by the Editors. If unsolicited, the authors are advised to contact the Editor-in-Chief (endocrine_eic@libero.it) with an outline of the proposed review and CV of the authors.

    This type of article has a word limit of 2000 and no more than 100 references.

    4. New Horizons in

    This contribution should be based on the outcomes of a scientific meeting and will be devoted to underline open issues as well as future basic and clinical research perspectives in an endocrine field. This type of article has a word limit of 2000 and no more than 50 references. Interested authors should contact directly the Editor-in-Chief (endocrine_eic@libero.it) submitting the meeting scientific program and an outline of their work.

    5. Meta-analysis

    This contribution should be based on a rigorous methodological/statistical approach described in detail in the methods section applied to a relevant clinical or basic issue. This work could also be submitted to statistical revision. Word limit is 3000 with no more than 100 references.

    6. Viewpoint

    This contribution should be solicited by the Editors and deal with a controversial topic in either basic or clinical endocrinology on which the author, a leading expert in the field, is invited to express his views and interpretation of current literature. This type of article has a word limit of 1500, 1 figure or table and no more than 30 references.

    7. Editorial

    This contribution should be solicited by the Editors and relates to the topic of one or more contributions published in the same issue of the journal. This type of article has a word limit of 1500 and no more than 20 references.

    8. Research Letter

    This contribution contains particularly original preliminary basic or clinical data presented in a very concise way (no abstract, word limit of 1250, 1 table of figure and maximum 20 references).

    9. Endocrine Genetics/Epigenetics

    This contribution contains novel insights in the genetics/epigenetics in endocrine physiology and diseases. Data should be presented in a concise way (word limit of 2000, 2 table or figure and maximum 30 references.

    10. Book review

    This contribution should be a short evaluation from an expert in the field on a relevant book in a certain area of endocrinology. This article should not exceed 750 words and no references are allowed.

    11. Letter to the Editor

    Text is limited to 750 words, with no abstract. There may be 1 figure, up to 3 references, and no more than 3 authors, with author affiliations only including main institution, place name and (state plus) country (i.e. no departments, etc).

    12. Endocrine Imaging

    Text is limited to 500 words, with no abstract, and illustrative of 1 Figure in which a particularly significant and original result of an imaging technique (e.g. MRI, CT, ultrasound) obtained during the diagnostic process of an endocrine disease should be included. No more than 3 references and 3 authors (with author affiliations only including main institution, place name and (state plus) country) are allowed.

    13. Pros and Cons in Endocrine Practice

    This contribution should deal with a controversial topic in endocrine practice in which pros and cons of an endocrine disease treatment or diagnostic process are examined and reported in a balanced and constructive way. A proposed algorithm or indication for an integrated approach should be produced. This type of article has a word limit of 2000, 1 figure and 1 table, no more than 50 references and can be written by a single author reviewing the two sides of the topic or by two authors each dealing with one aspect of the topic.

    14. Endocrine Methods and Techniques

    This contribution contains the description of a previously unreported research method or modification of an already known method particularly relevant to the endocrine field. New laboratory assays for hormone measurement as well as new diagnostic techniques or new applications of a diagnostic technique are also eligible for this manuscript category. Data should be presented in a concise way (word limit of 1500, 1 table or figure and maximum 25 references).

    15. Endocrine Trials

    This contribution is devoted to registered clinical trials in which treatments for an endocrine or metabolic disease are studied. Manuscripts can deal with the description of the protocol of a trial, can report data from interim analysis of an ongoing clinical trial, can report preliminary or final results of the trial as well as post-hoc analysis of the trial. The authors are invited not to exceed 2500 words and 75 references for reporting final results of a trial. Interim analysis or preliminary data of an ongoing clinical trial as well as post-hoc analysis of a trial should not exceed 1500 words and 50 references. The authors should not exceed 1000 words and 30 references for the description of the protocol of a new trial.

    16. Side Effects of Endocrine Treatments

    Text is limited to 500 words, with no abstract and only one Figure if strictly necessary, with the description of a potential side effect not previously reported which occurred during the treatment with an endocrine drug or of an endocrine disease. No more than 3 references and 3 authors (with author affiliations only including main institution, place name and (state plus) country) are allowed.

    17. Clinical Management of Endocrine Diseases

    This contribution should discuss the practical aspects of the management of an endocrine or metabolic disease with particular reference to critical aspects of the clinical guidelines in the specific field if available. Resulting decisional diagnostic and therapeutic algorithms should be aimed at helping clinicians in their daily practice. This type of article is generally invited, has a word limit of 2000, no more than 2 figures and 75 references.

    18. Position statements/Guidelines

    Editors of Endocrine can appoint a panel of authoritative experts to write a position paper/guideline article on a new or controversial clinical topic based on available evidence analyzed by the Grade system. Unsolicited position statement and/or guideline papers from expert panels can be submitted to Endocrine but authors are advised to contact in advance the Editor-in-Chief (endocrine_eic@libero.it) with an outline of the proposed article and CV of the authors. This type of article should not exceed 3000 words and 250 references.

     

    主编辑

     

    Andrea Giustina,意大利

     

    副主编:

     

    Sebastiano Filetti; 意大利罗马

    Carmine Gazzaruso; Vigevano,意大利

    Riccarda Granata; 都灵,意大利

    安德烈伊西托里 意大利罗马

    Marco Losa; 米兰,意大利

    保罗·马尼 米兰,意大利

    Gherardo Mazziotti; 曼托瓦,意大利

    Valter Torri; 米兰,意大利

    Giovanni Vitale; 米兰,意大利

    玛丽亚·基亚拉·扎泰利 费拉拉,意大利

     

    编委会:

     

    尼古拉·阿巴特 GalvestonTXUSA

    Abrahamsen; 哥本哈根,丹麦

    罗伯特·阿德勒; RichmondVAUSA

    Maria Alevizaki; 希腊雅典

    Emanuela Arvat; 都灵,意大利

    Giuseppe Banfi; 米兰,意大利

    安妮·巴利 马赛,法国

    Teresita Bellido; IndianapolisINUSA

    迈克尔·伯格曼 New YorkNYUSA

    Matthias Bluher; 莱比锡,德国

    马雷克·博拉诺夫斯基 弗罗茨瓦夫,波兰

    Jens Bollerslev; 奥斯陆,挪威

    菲利普·卡隆 图卢兹,法国

    马可中央 意大利罗马

    胡安·何塞·Chillaron; 西班牙巴塞罗那

    Roberto Civitelli; Saint LouisMOUSA

    Adrian Daly; 列日,比利时

    亨利·法哈马尔 Solna,瑞典

    玛丽亚·弗莱谢 PortlandORUSA

    Monica Gadelha; 里约热内卢,巴西

    Eliza Geer; New YorkNYUSA

    卢卡·乔凡纳 贝林佐纳,瑞士

    Dario Giugliano; 那不勒斯,意大利

    Norbert Gleicher; New YorkNYUSA

    詹姆斯·亨尼斯 BostonMAUSA

    杰罗姆·赫尔曼 Los AngelesCAUSA

    Andrew HoffmanStanfordCAUSA

    Gianluca Iacobellis; MiamiFLUSA

    Silvio Inzucchi; 纽黑文,CT,美国

    Emmanuele Jannini; 意大利罗马

    Barbara Jarzarb; 格利维采,波兰

    Jens Jorgensen; 奥尔胡斯,丹麦

    Laurence Katznelson; StanfordCAUSA

    亚历山大·克鲁瓦 因斯布鲁克,奥地利

    彼得·刘 TorranceCAUSA

    安东·鲁格 维也纳,奥地利

    Monica Marazuela; 马德里,西班牙

    Moises Mercado; 墨西哥城

    安德烈·米莱维奇 弗罗茨瓦夫,波兰

    Ignacio Bernabeu-Moron; La Coruna,西班牙

    Demosthenes Panagiotakos; 希腊雅典

    Socrates Papapoulos; 莱顿,荷兰

    Robin Peeters; 鹿特丹,荷兰

    Natalia S. Pellegata; NeuherbergGermany

    卡尔蒙邮报; 纽约,NY,美国

    LD Premawardhana; 加的夫,英国

    Thomas Reinehr; Datteln,德国

    费南多·里瓦德内拉 鹿特丹,荷兰

    理查德·罗斯 谢菲尔德,英国

    Roberto Salvatori; BaltimoreMDUSA

    Stefan Schulz; 耶拿,德国

    Manuel Tena-Sempere; 科多巴,西班牙

    Anat Ben-Shlomo; Los AngelesCAUSA

    Dolores Shoback; San FranciscoCAUSA

    Julie A. Sosa; DurhamNCUSA

    安娜·斯帕尼奥利 ChicagoILUSA

    尼古拉斯·特里托斯 BostonMAUSA

    Apostolos Tsapas; 塞萨罗尼基,希腊

    保罗·瓦伦西 Bondy,法国

    AJ van der Lely; 鹿特丹,荷兰

    Francesc Villarroya; 西班牙巴塞罗那

    Marcella Walker; New YorkNYUSA

    苏珊韦布 西班牙巴塞罗那

    罗伯特·温斯坦 小石城,AR,美国

    Michael Mingzhao Xing; BaltimoreMDUSA

    Bulent Yildiz; 安卡拉,土耳其


  • 万维QQ千亿国际平台交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文千亿国际平台平台    E-mail:eshukan@163.com


  • 千亿国际平台问答最小化  关闭